The subcutaneous
biologic drugs and affiliated technologies market is projected to be worth
over USD 180 billion by 2030




Roots Analysis is pleased to announce the publication of its recent study,
titled “Subcutaneous Biologics,
Technologies and Drug Delivery Systems (3rd Edition), 2020-2030” report to its
list of offerings.





The
report provides a detailed study on the current market landscape and future
potential of biologics designed for subcutaneous administration. In addition,
the study provides an in-depth analysis of the formulation technologies and
drug delivery systems (focusing on large volume wearable injectors,
autoinjectors, pen injectors, needle-free injectors, drug reconstitution
systems, prefilled syringes and implants) that enable subcutaneous delivery of
the biologic drugs. Amongst other elements, the report features the following:


§
A detailed assessment of the current market landscape of
commercially available and clinical-stage biologics that are designed for
delivery via the subcutaneous route


§ A
case study on leading subcutaneous biologics (in terms of revenues generated),
featuring details on mechanism of action, development history, annual sales,
technology platform (if available), and a comparison of their intravenous and
subcutaneous formulations (if applicable).


§ An
assessment of the various subcutaneous formulation technologies along with
information on developers, type of pharmacological molecule, route of
administration, mechanisms of action and primary advantage(s).


§ An
insightful three-dimensional comparison of the subcutaneous formulation
technology developers, based on pipeline strength, supplier power of the
developer and primary advantages offered by their respective technologies.


§ Elaborate
profiles of key technology developers, featuring a brief overview of the company,
its technology portfolio, product portfolio, financial information (if
available), recent developments and an informed future outlook.


§ An
analysis of collaborations and
partnership agreements inked by the subcutaneous formulation technology
developers since 2011


§ An
in-depth review of the most advanced and popular subcutaneous drug delivery
systems, including large volume wearable injectors, autoinjectors, pen
injectors, needle-free injectors, drug reconstitution systems, prefilled
syringes and implants


§ A
comprehensive product competitiveness analysis of subcutaneous large volume
wearable injectors, subcutaneous autoinjectors, subcutaneous needle-free
injectors and pre-filled syringes


§ A
discussion on affiliated trends, key drivers and challenges, which are likely
to impact the industry's evolution, under a comprehensive SWOT framework


§
A detailed market forecast, featuring analysis of the
current and projected future opportunity across key market segments (listed
below):


§ Phase
of development


§
Approved


§
Pre-registration & Phase III


§
Phase II & Phase II/III





To request a customize report – https://www.rootsanalysis.com/reports/314/request-customization.html





§ Type
of molecule


§
Cell and gene therapies


§
Monoclonal antibodies


§
Proteins


§
Peptides (recombinant)


§
Vaccines


§
Others





§ Target
therapeutic area


§
Autoimmune disorders


§
Blood disorders


§
Bone disorders


§
Genetic disorders


§
Metabolic disorders


§
Neurological disorders


§
Oncological disorders


§
Respiratory disorders


§
Others





§ Type
of drug delivery system


§
Large volume wearable injectors


§
Autoinjectors


§
Prefilled syringes


§
Needle-free injectors


§
Drug reconstitution systems





§ Revenues
from licensing deals


§
Upfront payments


§
Milestone payments





§ Key
geographical regions


§
North America


§
Europe


§
Asia Pacific


§
Rest of the World





To request a sample report - https://www.rootsanalysis.com/reports/subcutaneous-biologics-delivery/request-sample.html





Key
companies covered in the report


§ Adocia


§ Ajinomoto
Bio-Pharma Services


§ Arecor


§ Alteogen


§ Ascendis
Pharma


§ Avadel
Pharmaceuticals


§ Camurus


§ Creative
BioMart


§ Creative
Biolabs


§ DURECT


§ Eagle
Pharmaceuticals


§ Halozyme
Therapeutics


§ MedinCell


§ Xeris
Pharmaceuticals


§ Serina
Therapeutics





For additional
details, please visit


https://www.rootsanalysis.com/reports/view_document/subcutaneous-biologics-delivery/314.html





Other Recent Offerings


1.
Global Autoinjectors
Market
(3rd Edition), 2020-2030


2.
Prefilled Syringes
Market
(5th Edition), 2020-2030


3.
Microneedles and Needle-Free Injection Systems


4.
China
Biopharmaceutical Contract Manufacturing Market, 2020 – 2030


5.
HPAPI and Cytotoxic
Drugs Manufacturing Market (3rd Edition), 2020-2030


6.
Novel coronavirus
(COVID-19): Preventive Vaccines, Therapeutics and Diagnostics in Development





About Roots Analysis


Roots
Analysis is one of the fastest growing market research companies, sharing fresh
and independent perspectives in the bio-pharmaceutical industry. The in-depth research,
analysis and insights are driven by an experienced leadership team which has
gained many years of significant experience in this sector. If you’d like help
with your growing business needs, get in touch at info@rootsanalysis.com





Contact Information


Roots
Analysis Private Limited


Gaurav
Chaudhary


+1
(415) 800 3415


ben.johnson@rootsanalysis.com


Facebook
- https://www.facebook.com/RootsAnalysis


LinkedIn
- https://www.linkedin.com/company/roots-analysis/mycompany/


Twitter
- https://twitter.com/RootsAnalysis